Towards Healthcare
Cell and Gene Therapy Tools and Reagents Market Increases USD 11.12 Bn in 2025

Cell and Gene Therapy Tools and Reagents Market Driving Future Growth

Based on market forecasts, the global cell and gene therapy tools and reagents market, projected at USD 10.04 billion in 2024, is expected to reach USD 27.3 billion by 2034, growing at a CAGR of 10.76% over the forecast period. The cell and gene therapy tools and reagents market is expanding due to growing CGT clinical trials as well as growing research and development. North America led the market due to the presence of strong industries.

Content

  • Insight Code: 6107
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The cell and gene therapy tools and reagents market in 2025 is valued at USD 11.12 billion and is projected to climb to USD 27.3 billion by 2034, with a CAGR of 10.76% over the forecast period.

North America is currently leading the cell and gene therapy tools and reagents market share 43% due to the presence of strong industries.

Some key players include Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group, and Miltenyi Biotec.

The cell and gene therapy tools and reagents include reagents, vectors, enzymes, culture media, PCR kits, plasmids, antibodies, and genome-editing tools.

The cell and gene therapy tools and reagents are used for developing, manufacturing, and delivering cell and gene therapies.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions